Steven K. Davidsen

Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines.

Keith B. Glaser, Michael J. Staver, Jeffrey F. Waring et al. · PubMed · 2003 · 524 citations

Histone Modifications, Hdac Inhibitors, Epigenetic Change +22

Discovery of Potent Nonpeptide Inhibitors of Stromelysin Using SAR by NMR

Philip J. Hajduk, George S. Sheppard, David G. Nettesheim et al. · Journal of the American Chemical Society · 1997 · 316 citations

Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA

Keith B. Glaser, Junling Li, Michael J. Staver et al. · Biochemical and Biophysical Research Communications · 2003 · 218 citations

Histone Modifications, Tumor Biology, Chromatin +11

Discovery of<i>N</i>-(4-(3-Amino-1<i>H</i>-indazol-4-yl)phenyl)-<i>N</i>‘-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-Aminoindazole-Based Orally Active Multitargeted Receptor Tyrosine Kinase Inhibitor

Yujia Dai, Kresna Hartandi, Zhiqin Ji et al. · Journal of Medicinal Chemistry · 2007 · 180 citations · Full text

Compound 17P, Drug Target, Chemoprevention Strategy +20

Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML

Jianbiao Zhou, Chonglei Bi, Jasinghe V. Janakakumara et al. · Blood · 2009 · 160 citations · Full text